Law360, New York (July 2, 2007, 12:00 AM EDT) -- In a recent public announcement, Johnson & Johnson disclosed that it may have violated the Foreign Corrupt Practices Act and had reported potential violations to the Department of Justice and the Securities and Exchange Commission. Johnson & Johnson’s disclosure highlights the risks of FCPA violations for the medical device industry.
It also reflects a broader trend of increased FCPA enforcement, as do recent cases involving multimillion dollar fines.
*Risks for medical device industry*
Medical device companies are particularly at risk with respect to FCPA violations. In...